Calibr, A Division Of Scripps Research

This is an early study to test the safety of a new two-part treatment for people with advanced breast cancer that has spread or cannot be removed by surgery. The treatment involves giving patients their own modified immune cells (CLBR001), followed by a biologic drug (ABBV-461) t…

This study is testing whether a new weekly injection called CLF065 can help control chronic pouchitis, a painful inflammation that can occur after certain bowel surgeries. About 20 adults with this condition will receive either the actual medication or a placebo injection for 13 …